Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-n
Patent
1997-05-23
1999-08-17
Wallenhorst, Maureen M.
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-n
436164, 702 19, G01N 3300
Patent
active
059393270
ABSTRACT:
A method which provides a quick simple means of assessing plasma or serum specimen integrity with respect to bile pigments is described. Application of the method simultaneously screens serum or plasma specimens for elevated levels of bilirubin (BR) and biliverdin (BV) by providing a measure of these interferents known as the bilirubin-biliverdin index or BBI. The method involves determination of concentrations of BV in a plasma or serum specimen, based on the results of spectrophotometric determinations of absorbance or reflectance measurements conducted in the near infrared region, and thereby a determination of the BBI in respect of the specimen and on the basis of the resulting BBI a decision as to acceptance or rejection of the sample.
REFERENCES:
patent: 3477818 (1969-11-01), Fried et al.
patent: 4839279 (1989-06-01), Kosaka et al.
patent: 4985360 (1991-01-01), Takahashi
patent: 5262304 (1993-11-01), Taniguchi
patent: 5278073 (1994-01-01), Grandjean
CME Telemetrix Inc.
Wallenhorst Maureen M.
LandOfFree
Measurement of bile pigments in serum or plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Measurement of bile pigments in serum or plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Measurement of bile pigments in serum or plasma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314567